Lavender for Anxiety

Verdict: Likely effective for anxiety as standardized oil

A standardized oral lavender oil preparation (Silexan) is one of the better-evidenced herbal options for anxiety, with several randomized trials and two meta-analyses showing a real benefit. That evidence does not transfer to lavender tea, ordinary capsules, or aromatherapy, and most of the key trials were industry-funded, so the overall grade is preliminary rather than strong.

B 🟡 B Preliminary Evidence Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

The grade rests on consistent randomized data for one specific product. A double-blind trial in generalized anxiety disorder (PMID 24456909, n=539) found 80 and 160 mg/day of Silexan reduced HAM-A anxiety scores significantly more than placebo, with the higher dose comparable to paroxetine. A smaller trial (PMID 19962288, n=77) showed it was about as effective as lorazepam, and a third (PMID 20512042, n=221) beat placebo in subsyndromal anxiety. Two meta-analyses (PMID 27861196; PMID 31792285) pooled these results and confirmed a significant effect.

It falls short of a top grade for two reasons. Almost all the pivotal trials were funded by the manufacturer, and NIH's Office of Dietary Supplements calls the evidence 'promising but limited' by sample sizes and funding. Crucially, the benefit is tied to the standardized oral oil, not to lavender tea, generic capsules, or inhaled aromatherapy, which were not what these trials tested.

Regulators and clinicians are mixed. The FDA recognizes lavender oil only as a safe flavoring, has not approved any anxiety claim, and has warned companies marketing it as a treatment; Cleveland Clinic notes its linalool component may ease anxiety but stays cautious. Lavender oil can also add to the sedative effect of benzodiazepines, alcohol, and similar drugs.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.62
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Taiwan Regulatory Restriction
Confidence
77%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.49
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.85
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.622
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine
PMID: 24456909 2014 RCT (double-blind) n = 539
Finding: Silexan 160 and 80 mg/day superior to placebo in reducing HAM-A total score (p < 0.01); HAM-A reductions 14.1 and 12.8 pts vs 9.5 pts placebo; 160 mg comparable to paroxetine 20 mg.
🟢 High quality ⚠️ Industry-funded Effect size: HAM-A MD ~4.6 pts vs placebo (160 mg); 60.3% achieved >=50% HAM-A reduction vs 37.8% placebo
View on PubMed
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder
PMID: 19962288 2010 RCT (double-blind) n = 77
Finding: HAM-A total score decreased to a similar extent in both groups (Silexan -11.3 pts/45%; lorazepam -11.6 pts/46%), indicating non-inferiority to lorazepam.
⚠️ Industry-funded
View on PubMed
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial
PMID: 20512042 2010 RCT (double-blind) n = 221
Finding: Silexan superior to placebo with greater anxiety reduction; response 76.9% vs 49.1% and remission 60.6% vs 42.6% (placebo).
⚠️ Industry-funded
View on PubMed
Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis (Generoso et al., J Clin Psychopharmacol 2017;37(1):115-117)
PMID: 27861196 2017 統合分析 n = 1,173
Finding: Pooled analysis of 5 placebo-controlled RCTs found Silexan significantly more effective than placebo in reducing anxiety symptoms.
Effect size: SMD favoring Silexan vs placebo (significant)
View on PubMed
Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis (Yap et al.)
PMID: 31792285 2019 統合分析 n = 645
Finding: Silexan 160 mg produced greater HAM-A decline than placebo and paroxetine; 80 mg comparable to paroxetine; favorable safety/tolerability.
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
LAVENDER, OIL (LAVANDULA OFFICINALIS CHAIX) source↗
L4e WHO
Supportive
L5c Cleveland Clinic
Cautious
linalool, which has been shown to reduce anxiety and lower blood pressure source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-anxiety-INT-lavender-001 繁體中文版 →